Marc Hilmi (@marchilmi) 's Twitter Profile
Marc Hilmi

@marchilmi

🇫🇷 🇺🇸 Medical oncologist MD PhD #GIOncology #PancreaticCancer #Bioinformatics #ImageAnalysis #DigitalPathology

ID: 1435488087874969604

calendar_today08-09-2021 06:20:26

136 Tweet

111 Followers

151 Following

OncLive.com (@onclive) 's Twitter Profile Photo

Outstanding and entertaining #StarWars themed lecture by Dr Wungki Park, MD MS on emerging targets and novel immunotherapy agents in #PancreaticCancer. A new hope emerges! Jonathan W Lee #ESMO25 #CancerResearch #Oncology

Outstanding and entertaining #StarWars themed lecture by Dr <a href="/CentralParkWMD/">Wungki Park, MD MS</a> on emerging targets and novel immunotherapy agents in #PancreaticCancer. A new hope emerges!

<a href="/Jonathanwlee23/">Jonathan W Lee</a> 
#ESMO25
#CancerResearch 
#Oncology
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

CARES-009: Perioperative camrelizumab plus rivoceranib in resectable hepatocellular carcinoma #ESMO25 #ESMOAmbassadors 👉 EFS: 42 vs 19 mo 👉 DFS: 42 vs 19 mo 👉 MPR: 35 vs 7% 🧐Very promising results, neoadjuvant strategies will be the future in HCC @myesmo EASL Education Milca Malary

CARES-009: Perioperative camrelizumab plus rivoceranib in resectable hepatocellular carcinoma
#ESMO25 #ESMOAmbassadors
👉 EFS: 42 vs 19 mo
👉 DFS: 42 vs 19 mo
👉 MPR: 35 vs 7%
🧐Very promising results, neoadjuvant strategies will be the future in HCC
@myesmo <a href="/EASLedu/">EASL Education</a> <a href="/ilca/">Milca Malary</a>
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D PDAC #ESMO25 #ESMOAmbassadors 👉 ORR: 41%, DCR: 97% 👉 mPFS: 5.5 mo 👉 1-yr OS rate 92% 🧐 very promising, but secondary resistance may be concern > earlier line & combinations? @myesmo

Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D PDAC
#ESMO25 #ESMOAmbassadors
👉 ORR: 41%, DCR: 97%
👉 mPFS: 5.5 mo
👉 1-yr OS rate 92%
🧐 very promising, but secondary resistance may be concern &gt;  earlier line &amp; combinations?
@myesmo
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

HRS-4642 combined with gemcitabine and nab-paclitaxel in KRAS-G12D PDAC #ESMO25 #ESMOAmbassadors 👉 ORR: 63%, DCR 92% 👉 6mo PFS rate: 89% 👉 manageable safety 🧐 KRASi are the future in 1L… @myesmo

HRS-4642 combined with gemcitabine and nab-paclitaxel in KRAS-G12D PDAC
#ESMO25 #ESMOAmbassadors
👉 ORR: 63%, DCR 92%
👉 6mo PFS rate: 89%
👉 manageable safety
🧐 KRASi are the future in 1L…
@myesmo
Benjamin Besse (@benjaminbessemd) 's Twitter Profile Photo

KRAS inhibitors in NSCLC: -G12Di: coming soon to meet a major unmet need — same activity in smokers vs never-smokers? -G12Ci: expanding field, active in both naïve and post-sotorasib/adagrasib pts. Excellent summary Ignacio Garrido-Laguna #ESMO25

KRAS inhibitors in NSCLC:
-G12Di: coming soon to meet a major unmet need — same activity in smokers vs never-smokers?
-G12Ci: expanding field, active in both naïve and post-sotorasib/adagrasib pts.
Excellent summary <a href="/GarridoLagunaMD/">Ignacio Garrido-Laguna</a>  #ESMO25
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

Pancreas Wars: A New Hope ⚔️✨ Had a blast on stage with this rockstar panel at #ESMO25. Ben Westphalen Grainne O'Kane Sara Monica Pancreas is heating up 🔥next wave of precision oncology Just hold my drink and watch these rebels jam. 🎸 #PancreasWars #PrecisionOncology #TeamScience

Pancreas Wars: A New Hope ⚔️✨
Had a blast on stage with this rockstar panel at #ESMO25. <a href="/BenWestphalen/">Ben Westphalen</a> <a href="/graokane/">Grainne O'Kane</a> Sara Monica 

Pancreas is heating up 🔥next wave of precision oncology
Just hold my drink and watch these rebels jam. 🎸
#PancreasWars #PrecisionOncology #TeamScience
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

The Force was strong at the poster session ⚔️✨ Caught up with the Precision Oncology 🇩🇪 Couple Ben Westphalen & Nicolas from INSERM. 🔥 BEST POSTER 🔥 #CLDN182 & #Tissue Factor targeting how and how better?! #ESMO25 #PancreasWars #PrecisionOncology #TeamScience #ESMO25

The Force was strong at the poster session ⚔️✨ Caught up with the Precision Oncology 🇩🇪 Couple <a href="/BenWestphalen/">Ben Westphalen</a> &amp; Nicolas from INSERM.

🔥 BEST POSTER 🔥
#CLDN182 &amp; #Tissue Factor targeting how and how better?!

#ESMO25 #PancreasWars #PrecisionOncology #TeamScience #ESMO25
Layal Al Mahmasani (@layalmahmasani) 's Twitter Profile Photo

✨Excited to share a new chapter! I recently joined the Division of Hematology-Oncology at American University of Beirut Medical Center American University of Beirut as a faculty member. After 2 incredible years Memorial Sloan Kettering Cancer Center, I’m deeply grateful to be back home #patientcare #research #cancercare #Lebanon

✨Excited to share a new chapter! I recently joined the Division of Hematology-Oncology at <a href="/AUBMC_Official/">American University of Beirut Medical Center</a> <a href="/AUB_Lebanon/">American University of Beirut</a> as a faculty member. After 2 incredible years <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>, I’m deeply grateful to be back home #patientcare #research #cancercare #Lebanon
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

Entering this house of Titans 🏛️✨ Kontzerhouse Berlin An incredible night at the Presidential Dinner with Pancreas Team, Phase I leads and future Scientific Committee co-chairs. Grateful to share space with brilliant minds shaping oncology’s future. #ESMO25 #TeamScience

Entering this house of Titans 🏛️✨
Kontzerhouse Berlin 

An incredible night at the Presidential Dinner with Pancreas Team, Phase I leads and future Scientific Committee co-chairs.

Grateful to share space with brilliant minds shaping oncology’s future.

#ESMO25 #TeamScience
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

As the M- President (ESMO - Eur. Oncology not the other one) said, this was special because of the #People. #Friends and #colleagues~ Thank you~ 🙏😊 A dose of 5K on the day of talk is a must! Grainne O'Kane we are absolutely implementing this for future 🤩 #ESMO25 Steve Maron Mike Foote

As the M- President (<a href="/myESMO/">ESMO - Eur. Oncology</a> not the other one) said, this was special because of the #People. #Friends and #colleagues~ 
Thank you~ 🙏😊

A dose of 5K on the day of talk is a must! <a href="/graokane/">Grainne O'Kane</a> we are absolutely implementing this for future 🤩 #ESMO25 <a href="/SteveMaronMD/">Steve Maron</a> <a href="/MikeFooteMD/">Mike Foote</a>
Michael May (@michaelmaymd) 's Twitter Profile Photo

nature.com/articles/s4158… We found that pancreatic cancer cell transcriptional profiles resemble their future metastatic niche, potentially enabling prediction of organotropism. The results of years of collaboration with Gulam Abbas Manji bizarMD Mori Alissa Michel, and many others.

Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

Quietest before the sunrise 🌅 Morning runs 🏃🏻‍♂️powering the science 🧬 Fantastic collab with Wil & Yuval from Benjamin D. Greenbaum on #PDAC #immunology Big welcome to Vincenzo Nasca joining the #sPARKLab. Momentum is real. Marc Hilmi MSK Department of Medicine #PancreasWars Fred's Team

Quietest before the sunrise 🌅
Morning runs 🏃🏻‍♂️powering the science 🧬 Fantastic collab with Wil &amp; Yuval from <a href="/bengrbm/">Benjamin D. Greenbaum</a> on #PDAC #immunology 

Big welcome to <a href="/nasca_vincenzo/">Vincenzo Nasca</a> joining the #sPARKLab. Momentum is real.
<a href="/MarcHilmi/">Marc Hilmi</a> <a href="/MSK_DeptOfMed/">MSK Department of Medicine</a> 
#PancreasWars <a href="/FredsTeam/">Fred's Team</a>
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

Practice-changing contributions and a beautiful narrative of a career dedicated to advancing oncology #GastricCancer #EsophagealCancer Congrats 🎉 to Yelena Y. Janjigian MD 🪑#Endowment Full circle. Her journey began with Stephen D. Nimer, MD 🌟#GIOnc #Leadership #sPARKLab 💜 MSK Department of Medicine

Practice-changing contributions and a beautiful narrative of a career dedicated to advancing oncology #GastricCancer #EsophagealCancer 

Congrats 🎉 to <a href="/YJanjigianMD/">Yelena Y. Janjigian MD</a> 🪑#Endowment 

Full circle. Her journey began with <a href="/DrSDNimer/">Stephen D. Nimer, MD</a> 🌟#GIOnc #Leadership #sPARKLab 💜 <a href="/MSK_DeptOfMed/">MSK Department of Medicine</a>
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

From pancreas to liver, Covering all the guts of innovation 😉 Join us Nov 20–21 at MSK for the Updates in Hepatopancreatobiliary Malignancy Symposium! 🧠 Translational science meets clinical impact 🔗 mskcc.cloud-cme.com/course/courseo…📷 #GIOnc #HPB #PancreasCancer #ColorectalCancer

From pancreas to liver, Covering all the guts of innovation 😉

Join us Nov 20–21 at MSK for the Updates in Hepatopancreatobiliary Malignancy Symposium!
🧠 Translational science meets clinical impact
🔗 mskcc.cloud-cme.com/course/courseo…📷

#GIOnc #HPB #PancreasCancer #ColorectalCancer
Wungki Park, MD MS (@centralparkwmd) 's Twitter Profile Photo

Fearless #HBP #HumansBeyondPatients AI pathology to #RAS biology 🧬 the revolution in #PancreaticCancer is real. We’re finally moving the needle with novel #KRAS inhibitors & smart immune modulation. Bring your story & fuel the mission 🚴🏼 👉 mskcc.convio.net/goto/FearlessH… #DDR #BRCA

Fearless #HBP #HumansBeyondPatients

AI pathology to #RAS biology 🧬 the revolution in #PancreaticCancer is real.
We’re finally moving the needle with novel #KRAS inhibitors &amp; smart immune modulation.

Bring your story &amp; fuel the mission 🚴🏼
👉 mskcc.convio.net/goto/FearlessH…

#DDR #BRCA
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥off the press Astellas Confirms Phase 2 GLEAM Trial Did Not Meet Primary Endpoint of Overall Survival in Patients with Metastatic Pancreatic Cancer 👉published a couple of days ago, but still disappointing. CLD 18.2 not (yet?) a tumor agnostic biomarker... ESMO - Eur. Oncology

🔥off the press
Astellas Confirms Phase 2 GLEAM Trial Did Not Meet Primary Endpoint of Overall Survival in Patients with Metastatic Pancreatic Cancer
👉published a couple of days ago, but still disappointing. CLD 18.2 not (yet?) a tumor agnostic biomarker...
<a href="/myESMO/">ESMO - Eur. Oncology</a>